View Exam | PowerPak

1. Monoclonal antibody products are authorized to treat which group of patients with confirmed COVID-19?

A. Any patient B. Any non-hospitalized patient ≥ 18 years of age C. Non-hospitalized patients ≥ 12 years of age at high risk for severe disease D. Patients hospitalized for COVID-19 ≥ 12 years of age requiring oxygen support

2. A 32-year-old patient with T2D and a BMI of 37 has mild COVID-19, with onset of symptoms four days ago. What is the most appropriate management for this patient?

A. Symptom monitoring and home isolation B. Dexamethasone C. Monoclonal antibodies D. Remdesivir

3. The NIH currently recommends use of remdesivir in which group of hospitalized patients?

A. Not requiring supplemental oxygen B. Requiring supplemental oxygen C. Requiring oxygen through high-flow device or noninvasive ventilation D. Requiring mechanical ventilation or ECMO E. A and B F. B and C

4. The NIH currently recommends against use of dexamethasone in which group of hospitalized patients?

A. Not requiring supplemental oxygen B. Requiring supplemental oxygen C. Requiring oxygen through high-flow devise or noninvasive ventilation D. Requiring mechanical ventilation or ECMO E. A and B F. C and D

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Monoclonal antibody products are authorized to treat which group of patients with confirmed COVID-19?

2. A 32-year-old patient with T2D and a BMI of 37 has mild COVID-19, with onset of symptoms four days ago. What is the most appropriate management for this patient?

3. The NIH currently recommends use of remdesivir in which group of hospitalized patients?

4. The NIH currently recommends against use of dexamethasone in which group of hospitalized patients?

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Monoclonal antibody products are authorized to treat which group of patients with confirmed COVID-19?

2. A 32-year-old patient with T2D and a BMI of 37 has mild COVID-19, with onset of symptoms four days ago. What is the most appropriate management for this patient?

3. The NIH currently recommends use of remdesivir in which group of hospitalized patients?

4. The NIH currently recommends against use of dexamethasone in which group of hospitalized patients?

« Return to Activity

Customers who Purchased
this Activity also Purchased